ImmUniverse
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
- Description
By looking into the common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis, ImmUniverse aims at improving diagnostic and therapeutic options for patients living with both conditions. Through molecular profiling techniques, the consortium will identify signatures of biomarkers and mechanistic principles which reveal information on disease severity and progression enabling personalised therapy decisions for each patient at the right time.
- Coordinator
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 60 months (January 2020 - December 2024)
- Project funding
- € 31,000,000.00
- Project partners
- 26
- Technology readiness level
- 0-2
- Project website
- https://www.immuniverse.eu